Quoin Pharmaceuticals Ltd. ADR buy melinda
Zusammenfassung
Diese Einschätzung wurde am 10.01.22 mit einem Endkurs von 22,00 € beendet. Die BUY Einschätzung von melinda schloss mit einer Rendite von -79,82 %. melinda hat 50% Zuversicht bei dieser EinschätzungQuoin Pharmaceuticals (Symbol QNRX) (WKN A3DMEZ) is a publicly traded pharmaceutical company that specializes in developing and commercializing innovative therapeutics for a diverse range of medical conditions. Its skilled team of researchers and industry experts work tirelessly to identify and harness breakthrough technologies that can enhance patient outcomes, improve the overall healthcare landscape, and create sustainable shareholder value. Focused on addressing unmet medical needs and utilizing its unique expertise, Quoin Pharmaceuticals is committed to bringing transformative, life-changing medication to market. With its shares trading on the stock exchange, investors have the opportunity to support the cutting-edge research that drives the company's robust pipeline of promising treatments.
Rendite ohne Dividenden (%)
| Name | 1W | 1M | 1J | 3J |
|---|---|---|---|---|
| Quoin Pharmaceuticals Ltd. ADR | - | - | - | - |
| iShares Core DAX® | -0,92 % | -1,08 % | 12,16 % | 16,80 % |
| iShares Nasdaq 100 | 0,37 % | -0,56 % | 38,62 % | 49,37 % |
| iShares Nikkei 225® | 2,22 % | -2,83 % | 19,01 % | 4,64 % |
| iShares S&P 500 | -0,03 % | -0,79 % | 28,48 % | 42,48 % |
Kommentare von melinda zu dieser Einschätzung
In der Diskussion Quoin Pharmaceuticals Ltd. ADR diskutieren
In der Diskussion Trading Quoin Pharmaceuticals Ltd. ADR
Beendete Einschätzungen von melinda zu Quoin Pharmaceuticals Ltd. ADR
Quoin Pharmaceuticals Ltd. ADR
01.02.23
01.02.24
15.04.23
